Advertisement
U.S. markets closed

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
1.4500+0.0700 (+5.07%)
At close: 04:00PM EDT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
33,791
33,791
26,924
26,235
25,459
Operating Income
-33,791
-33,791
-26,924
-26,235
-25,459
Net Non Operating Interest Income Expense
1,326
1,326
528
99
121
Other Income Expense
4,810
4,810
1,645
-119
2,833
Pretax Income
-27,655
-27,655
-24,751
-26,255
-22,505
Tax Provision
97
97
84
49
0
Net Income Common Stockholders
-27,752
-27,752
-24,835
-26,304
-22,505
Diluted NI Available to Com Stockholders
-27,752
-27,752
-24,835
-26,304
-22,505
Basic EPS
-0.51
-
-0.43
-0.49
-0.56
Diluted EPS
-0.51
-
-0.43
-0.49
-0.56
Basic Average Shares
64,057
-
58,030
53,513
40,339
Diluted Average Shares
64,057
-
58,030
53,513
40,339
Total Operating Income as Reported
-
-
-
-26,235
-25,459
Total Expenses
33,791
33,791
26,924
26,235
25,459
Net Income from Continuing & Discontinued Operation
-27,752
-27,752
-24,835
-26,304
-22,505
Normalized Income
-30,638
-30,638
-26,049
-26,217
-25,338
Interest Income
1,326
1,326
528
99
121
Net Interest Income
1,326
1,326
528
99
121
EBIT
-33,791
-33,791
-26,924
-26,235
-25,459
EBITDA
-33,388
-33,388
-26,532
-25,783
-25,013
Reconciled Depreciation
403
403
392
452
446
Net Income from Continuing Operation Net Minority Interest
-27,752
-27,752
-24,835
-26,304
-22,505
Total Unusual Items Excluding Goodwill
4,810
4,810
1,645
-119
2,833
Total Unusual Items
4,810
4,810
1,645
-119
2,833
Normalized EBITDA
-38,198
-38,198
-28,177
-25,664
-27,846
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,924
1,924
431.1545
-31.535
0